Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 01, 2024, titled "Aurobindo Pharma receives USFDA Approval for Cephalexin Tablets USP, 250 mg and 500 mg".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 01, 2024, titled "Aurobindo Pharma receives USFDA Approval for Cephalexin Tablets USP, 250 mg and 500 mg".